Agreed! March 22 cc notes: 63. 1:26:00 production-

New Post Public Reply Private Reply Replies (2) Message Board
grow melsdollars #85371
780
Agreed!

March 22 cc notes:
63. 1:26:00 production- Samsung is still comfortable with us and has assured us they will make any amount of product we want. We feel strong about Samsung.


66. 1:29:44 vials- Samsung could produce millions of vials a month. Right now we have about 500,000 vials, bulk product for 600,000 vials, and some from the past. The total number comes to about 1.3 million vials that we could have available if we are trying to sell.

Read More: https://investorshangout.com/post/view?id=609...z6rCzsVG6T


March 8 cc notes
27. 41:11 The Samsung CEO (manufacturer) told Cytodyn that they are ready to support whatever amount you guys need.

Read More: https://investorshangout.com/post/view?id=608...z6rD0TCPMl

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
There are no guarantees in investing. No one should consider these pages or posts to be financial advice. Everyone has a responsibility to verify and thoroughly learn more than what is referenced or written here, and everyone must take responsibility for their own investing decisions.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Navigating Early Career Challenges: Strategies for Success

Updated Category News Views 159

Understanding the Challenges of Early Career Professionals As the new generation of professionals prepares to step into the workforce, they often face a variety of challenges. Recent insights from professionals reveal common hurdles that individuals might encounter early in their careers. Understanding these challenges is the first step toward successfully navigating...

Continue Reading
Pharming Takes Strategic Step with Public Offer for Abliva AB

Updated Category News Views 387

Pharming Sets a New Course with Strategic Acquisition Strengthening the Pipeline with a First-in-Disease Asset Pharming Group N.V. has recently made headlines with its ambitious public cash offer for Abliva AB. This strategic acquisition, valued at approximately US$66.1 million, aims to advance Pharming's late-stage pipeline significantly. At the heart of this acquisition...

Continue Reading
Golden Sun Health Tech Launches Joint Venture in Tourism Sector

Updated Category News Views 113

Golden Sun Health Technology Group Limited Ventures into Cultural Tourism Golden Sun Health Technology Group Limited, previously known as Golden Sun Education Group Limited (NASDAQ: GSUN), has made a notable step forward by launching a joint venture aimed at tapping into the cultural tourism market. Through its wholly-owned subsidiary, Shanghai Golden Sun Gongyu Education...

Continue Reading
BlackRock Municipal Income Fund Announces Merger Dates and Changes

Updated Category News Views 520

BlackRock Municipal Income Fund Transition Announcement BlackRock Municipal Income Fund, Inc. (NYSE: MUI, referred to as the “Fund”) is set to undergo an exciting transition. The Fund will change from an exchange-listed closed-end fund to an unlisted continuously-offered closed-end fund, which will conduct quarterly repurchases of its shares. This new venture will be...

Continue Reading
Understand Your Rights: Join CrowdStrike Class Action Today

Updated Category News Views 152

Understanding the CrowdStrike Holdings Class Action Attention shareholders of CrowdStrike Holdings, Inc. (NASDAQ: CRWD): If you acquired shares during the specified class period, it’s important to understand your rights regarding an ongoing class action. Recent developments have raised concerns about the company's operations, particularly in relation to its flagship...

Continue Reading